Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
Holding ACAD?
Track your performance easily
See the Price Targets and Ratings of:
ACAD Analyst Ratings
Moderate Buy
11 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACAD Stock 12 Month Forecast
Average Price Target
$27.42
▲(66.28% Upside)
| Highest Price Target$39.00 | Average Price Target$27.42 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
Reiterated
11/20/24
Leerink Partners
Reiterated
11/17/24
Oppenheimer
Reiterated
11/08/24
Morgan Stanley
Reiterated
11/07/24
TD Cowen
Assigned
11/07/24
H.C. Wainwright
Reiterated
11/07/24
Needham
Reiterated
11/07/24
Stifel Nicolaus
Reiterated
11/07/24
JMP Securities
Reiterated
11/07/24
RBC Capital
Reiterated
11/06/24
Robert W. Baird
$28
Buy
69.80%
Upside
Reiterated
11/06/24
Buy Recommendation for Acadia Pharmaceuticals Driven by Strong Nuplazid Performance and Promising Pipeline
J.P. Morgan
―
Buy
―
Reiterated
11/06/24
ACADIA Pharmaceuticals: Strong Sales and Strategic Vision Underpin Buy Rating
Guggenheim
―
Buy
―
Reiterated
10/17/24
Guggenheim reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)Guggenheim analyst Yatin Suneja reiterated a Buy rating on Acadia Pharmaceuticals (NASDAQ: ACAD).
Raymond James
―
Hold
―
Initiated
10/10/24
Acadia Pharmaceuticals reinstated with a Market Perform at Raymond JamesAcadia Pharmaceuticals reinstated with a Market Perform at Raymond James
BMO Capital
$31
Buy
87.99%
Upside
Reiterated
09/27/24
Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), ACADIA Pharmaceuticals (ACAD)
Best Analysts Covering ACADIA Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy ACAD and Sell After:
1 Month
xxx
Success Rate
17/34 ratings generated profit
Average Return
+0.59%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +0.59% per trade.
3 Months
xxx
Success Rate
16/25 ratings generated profit
Average Return
+6.40%
assigned a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.00% of your transactions generating a profit, with an average return of +6.40% per trade.
1 Year
Success Rate
14/25 ratings generated profit
Average Return
+6.15%
assigned a buy rating 16 days ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 56.00% of your transactions generating a profit, with an average return of +6.15% per trade.
2 Years
xxx
Success Rate
12/34 ratings generated profit
Average Return
+8.69%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.29% of your transactions generating a profit, with an average return of +8.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACAD Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
13
13
12
10
11
Buy
0
5
5
6
2
Hold
6
7
8
9
6
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
19
26
26
26
19
Each month's total comprises the sum of three months' worth of ratings.
ACAD Financial Forecast
ACAD Stock Forecast FAQ
What is ACAD’s average 12-month price target, according to analysts?
Based on analyst ratings, ACADIA Pharmaceuticals’s 12-month average price target is $27.42.
What is ACAD’s upside potential, based on the analysts’ average price target?
ACADIA Pharmaceuticals has 66.28% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACAD a Buy, Sell or Hold?
ACADIA Pharmaceuticals has a consensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings.
What is ACADIA Pharmaceuticals’s price target?
The average price target for ACADIA Pharmaceuticals is $27.42. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 66.28% Increase from the current price of $16.49.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 66.28% Increase from the current price of $16.49.
What do analysts say about ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of ACAD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.